Divisions of Pulmonary and Sleep Medicine, Children's Mercy Hospital, Kansas City, Missouri.
Allergy and Immunology, Children's Mercy Hospital, Kansas City, Missouri.
J Clin Sleep Med. 2023 Jan 1;19(1):27-34. doi: 10.5664/jcsm.10238.
While previous studies have suggested a high prevalence of sleep disorders in children with 22q deletion syndrome (22qDS), they were limited by potential selection bias. In the current investigation, we assessed sleep characteristics in 100 consecutive children presenting to a 22qDS multidisciplinary clinic.
An observational retrospective case series of consecutive children presenting to 22qDS multidisciplinary clinic was performed. Children aged 2 to 17 years of age were included, and data were abstracted including sleep characteristics (sleep history, Childhood Sleep Habits Questionnaire [CSHQ], and free response questions), comorbid medical conditions, and demographics.
Overall, 100 children were included in analysis, 85% of whom had scores on the CSHQ consistent with clinically meaningful sleep disorder. Sleep problems were common in all domains of the CSHQ, including daytime sleepiness (66%), sleep-onset delay (54%), parasomnias (52%), night wakings (52%), sleep-disordered breathing (49%), sleep duration (45%), bedtime resistance (38%), and sleep anxiety (33%). Overall CSHQ score was significantly associated with daytime behavioral problems and speech delay [F = 10.4, < .001, adjusted = 0.16]. The most common interventions reported to be helpful for sleep by parents were behavioral (routine, bedtime story), environmental (light avoidance at night, calming music), and pharmacologic (melatonin, clonidine).
These data confirm a high prevalence of sleep disorders in a large, unselected sample of children with 22qDS, and suggest an important relationship between sleep dysfunction and daytime behavioral challenges. Our findings highlight the potential role for multimodal treatment approaches including behavioral, environmental, and pharmacologic interventions.
Ingram DG, Raje N, Arganbright JM. Sleep profiles in children with 22q deletion syndrome: a study of 100 consecutive children seen in a multidisciplinary clinic. . 2023;19(1):27-34.
虽然先前的研究表明,22q 缺失综合征(22qDS)患儿中睡眠障碍的发病率很高,但这些研究受到潜在选择偏倚的限制。在本次研究中,我们评估了 100 例连续就诊于 22qDS 多学科门诊的患儿的睡眠特征。
对连续就诊于 22qDS 多学科门诊的患儿进行了一项观察性回顾性病例系列研究。纳入年龄在 2 至 17 岁的患儿,提取的数据包括睡眠特征(睡眠史、儿童睡眠习惯问卷 [CSHQ] 和自由回答问题)、合并症医疗状况和人口统计学特征。
共有 100 例患儿纳入分析,其中 85%的患儿 CSHQ 评分提示存在有临床意义的睡眠障碍。所有 CSHQ 领域均存在睡眠问题,包括日间嗜睡(66%)、入睡延迟(54%)、睡眠相关异常(52%)、夜醒(52%)、睡眠呼吸障碍(49%)、睡眠时间(45%)、入睡抗拒(38%)和睡眠焦虑(33%)。总体 CSHQ 评分与日间行为问题和语言延迟显著相关 [F = 10.4,<.001,调整后 = 0.16]。父母报告有助于睡眠的最常见干预措施是行为干预(常规、睡前故事)、环境干预(夜间避免光照、舒缓音乐)和药物干预(褪黑素、可乐定)。
这些数据证实,在一个大型、未经选择的 22qDS 患儿样本中,睡眠障碍的发病率很高,并提示睡眠功能障碍与日间行为挑战之间存在重要关系。我们的研究结果强调了多模式治疗方法的潜在作用,包括行为、环境和药物干预。
Ingram DG, Raje N, Arganbright JM. Sleep profiles in children with 22q deletion syndrome: a study of 100 consecutive children seen in a multidisciplinary clinic.. 2023;19(1):27-34.